Camp4 Therapeutics Corporation

NasdaqGM:CAMP Stock Report

Market Cap: US$291.8m

Camp4 Therapeutics Management

Management criteria checks 2/4

Camp4 Therapeutics' CEO is Josh Mandel-Brehm, appointed in Jan 2017, has a tenure of 9.58 years. total yearly compensation is $3.33M, comprised of 18% salary and 82% bonuses, including company stock and options. directly owns 0.45% of the company’s shares, worth $1.33M. The average tenure of the management team and the board of directors is 3.9 years and 6.1 years respectively.

Key information

Josh Mandel-Brehm

Chief executive officer

US$3.3m

Total compensation

CEO salary percentage18.03%
CEO tenure9.6yrs
CEO ownership0.5%
Management average tenure3.9yrs
Board average tenure6.1yrs

Recent management updates

Recent updates

Seeking Alpha • Jul 28

Camp4 Moves Into Human Trials -- The Upside Is Underpriced

Summary Camp4 Therapeutics remains a buy as CMP-002 transitions to first-in-human Phase 1/2 trials, shifting the story to a catalyst-driven setup. The pro forma cash position, bolstered by a $50M tranche, extends the runway into 2029, supporting execution through key clinical readouts. Valuation appears optically expensive on traditional multiples, but enterprise value remains modest, reflecting both execution risk and upside potential if clinical data validates the platform. Key risk centers on CMP-002's first-in-human translation; failure would likely drive a sharp valuation reset and force strategic pivots. Read the full article on Seeking Alpha
Analysis Article • Jul 18

We Think Camp4 Therapeutics (NASDAQ:CAMP) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. By way of example, Camp4 Therapeutics...
Analysis Article • Jul 02

Here's Why Camp4 Therapeutics (NASDAQ:CAMP) Must Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

CEO Compensation Analysis

How has Josh Mandel-Brehm's remuneration changed compared to Camp4 Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026n/an/a

-US$107m

Mar 31 2026n/an/a

-US$86m

Dec 31 2025US$3mUS$600k

-US$80m

Sep 30 2025n/an/a

-US$53m

Jun 30 2025n/an/a

-US$52m

Mar 31 2025n/an/a

-US$52m

Dec 31 2024US$2mUS$557k

-US$52m

Sep 30 2024n/an/a

-US$52m

Jun 30 2024n/an/a

-US$50m

Mar 31 2024n/an/a

-US$49m

Dec 31 2023US$696kUS$546k

-US$49m

Compensation vs Market: Josh's total compensation ($USD3.33M) is above average for companies of similar size in the US market ($USD1.57M).

Compensation vs Earnings: Josh's compensation has increased whilst the company is unprofitable.

CEO

Josh Mandel-Brehm (43 yo)

9.6yrs
Tenure
US$3,327,238
Compensation

Mr. Joshua Mandel-Brehm, also known as Josh, serves as an Independent Director at ProMIS Neurosciences, Inc. September 2021 and served as its Director since September 1, 2021. He has also been a founder an...

Leadership Team

NamePositionTenureCompensationOwnership
Joshua Mandel-Brehm
CEO, President & Director9.6yrsUS$3.33m0.45%
$ 1.3m
Richard Young
Founder & Independent Directorno dataUS$156.92k0.30%
$ 866.7k
Kelly Gold
Chief Financial Officerno dataUS$1.85m0.12%
$ 346.1k
Yuri Maricich
Chief Medical Officer3yrsUS$1.81m0.020%
$ 58.7k
Leonard Zon
Founder & Chairman of Scientific Advisory Boardno datano datano data
Caleb Moore
Chief Business Operations Officerno datano datano data
Daniel Tardiff
Chief Scientific Officerless than a yearno datano data
Michelle Gates
Senior VP & Chief People Officer5.1yrsno datano data
Alla Sigova
Senior Vice President of Platformno datano datano data
Satya Kuchimanchi
Senior Vice President of Technical Operations3.9yrsno datano data
3.9yrs
Average Tenure
46yo
Average Age

Experienced Management: CAMP's management team is considered experienced (3.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Joshua Mandel-Brehm
CEO, President & Director9.6yrsUS$3.33m0.45%
$ 1.3m
Richard Young
Founder & Independent Director10.6yrsUS$156.92k0.30%
$ 866.7k
Leonard Zon
Founder & Chairman of Scientific Advisory Boardno datano datano data
Steven H. Holtzman
Independent Director6.8yrsUS$164.11k0.17%
$ 506.6k
Douglas Williams
Independent Chairman1.4yrsUS$120.72k0.0040%
$ 11.6k
Andrew Schwab
Independent Director5.4yrsUS$12.69kno data
Amir Nashat
Independent Director11.6yrsUS$11.92kno data
Michael MacLean
Independent Directorless than a yearno datano data
Rachel Meyers
Member of Scientific Advisory Boardno datano datano data
David Bumcrot
Member of Scientific Advisory Boardno dataUS$501.93kno data
Murray Stewart
Independent Director1.4yrsUS$108.59k0%
$ 0
6.1yrs
Average Tenure
62.5yo
Average Age

Experienced Board: CAMP's board of directors are considered experienced (6.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/20 18:50
End of Day Share Price 2026/08/20 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Camp4 Therapeutics Corporation is covered by 8 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steven SeedhouseCantor Fitzgerald & Co.
Keay NakaeChardan Capital Markets, LLC
Anupam RamaJ.P. Morgan